StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP – Free Report) in a research note issued to investors on Friday. The brokerage issued a hold rating on the stock.
Retractable Technologies Stock Up 1.0 %
Shares of NYSE:RVP opened at $0.64 on Friday. The company has a market capitalization of $19.04 million, a price-to-earnings ratio of -1.18 and a beta of 1.98. Retractable Technologies has a 12-month low of $0.56 and a 12-month high of $1.34. The business has a 50-day moving average price of $0.69 and a 200 day moving average price of $0.90. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01.
Insider Buying and Selling
In related news, CEO Thomas J. Shaw bought 71,422 shares of the firm’s stock in a transaction that occurred on Friday, September 20th. The stock was purchased at an average cost of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the acquisition, the chief executive officer now owns 14,743,907 shares in the company, valued at approximately $12,090,003.74. This trade represents a 0.49 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In the last quarter, insiders purchased 176,545 shares of company stock valued at $132,531. Company insiders own 55.00% of the company’s stock.
Institutional Trading of Retractable Technologies
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Further Reading
- Five stocks we like better than Retractable Technologies
- Election Stocks: How Elections Affect the Stock Market
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Quiet Period Expirations Explained
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Calculate Return on Investment (ROI)
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.